First Horizon Advisors, Inc. Legend Biotech Corp Transaction History
First Horizon Advisors, Inc.
- $3.55 Billion
- Q4 2024
A detailed history of First Horizon Advisors, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 294 shares of LEGN stock, worth $9,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
294
Previous 249
18.07%
Holding current value
$9,440
Previous $12,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
84.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$241 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$219 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$192 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$184 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$183 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.38B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...